ArticleJournal of bone and mineral metabolism2019

Denosumab is effective toward glucocorticoid-induced osteoporosis patients complicated with rheumatic diseases regardless of prior anti-osteoporotic drugs.

Naoki Iwamoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.